Russell Investments Group
VVOS icon

Russell Investments Group’s Vivos Therapeutics VVOS Stock Holding History

Russell Investments Group’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,636
Closed -$236K – 2971
2022
Q3 		$236K Sell
14,636
-1,828
-11% -$55.7K ﹤0.01% 2505
2022
Q2 		$530K Sell
16,464
-528
-3% -$21.9K ﹤0.01% 2249
2022
Q1 		$1.14M Buy
16,992
+4,788
+39% +$313K ﹤0.01% 1896
2021
Q4 		$684K Buy
12,204
+10,338
+554% +$832K ﹤0.01% 2327
2021
Q3 		$188K Buy
+1,866
New +$196K ﹤0.01% 2787

Other funds holding VVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AF
Apexium Financial Dallas, Texas $2.06B AUM 15.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group's VVOS Position: Q4 2022 in Review

Russell Investments Group sold out of Vivos Therapeutics (VVOS) in Q4 2022, closing a stake of 14,636 shares — an estimated $236K sold.

Russell Investments Group first reported a position in VVOS in Q3 2021 and held it in 5 quarters. The position peaked at $1.14M in Q1 2022. 27 funds tracked by Wall St. Rank hold VVOS as of Q4 2022.

  • Russell Investments Group reported no remaining Vivos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 14,636 Vivos Therapeutics shares in Q4 2022, an estimated $236K.
  • Russell Investments Group first reported a position in Vivos Therapeutics in Q3 2021 and held it in 5 quarters.
  • Russell Investments Group's Vivos Therapeutics position peaked at $1.14M in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.